Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
278.17
+5.26 (1.93%)
Jan 29, 2026, 12:54 PM EST - Market open
Krystal Biotech Market Cap
Krystal Biotech has a market cap or net worth of $8.07 billion as of January 29, 2026. Its market cap has increased by 83.40% in one year.
Market Cap
8.07B
Enterprise Value
7.25B
1-Year Change
83.40%
Ranking
Category
Stock Price
$278.17
Market Cap Chart
Since September 20, 2017, Krystal Biotech's market cap has increased from $92.40M to $8.07B, an increase of 8,629.70%. That is a compound annual growth rate of 70.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 27, 2026 | 8.04B | 12.50% |
| Dec 31, 2025 | 7.15B | 58.67% |
| Dec 31, 2024 | 4.51B | 28.76% |
| Dec 29, 2023 | 3.50B | 71.56% |
| Dec 30, 2022 | 2.04B | 31.13% |
| Dec 31, 2021 | 1.56B | 31.54% |
| Dec 31, 2020 | 1.18B | 23.37% |
| Dec 31, 2019 | 958.50M | 219.71% |
| Dec 31, 2018 | 299.80M | 178.37% |
| Dec 29, 2017 | 107.70M | 16.56% |
| Sep 20, 2017 | 92.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jazz Pharmaceuticals | 10.03B |
| ABIVAX Société Anonyme | 9.41B |
| Axsome Therapeutics | 9.30B |
| Arrowhead Pharmaceuticals | 9.21B |
| Praxis Precision Medicines | 8.81B |
| Halozyme Therapeutics | 8.54B |
| Cytokinetics | 7.88B |
| Nuvalent | 7.88B |